Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders.

Journal of thrombosis and haemostasis : JTH - 1 Aug 2025

Ramanan Radha, Verstraete Andreas, Van Laer Christine, Freson Kathleen

Abstract excerpt

High-throughput sequencing, with its capacity to simultaneously sequence large volumes of genomic data, has evolved from a research-focused technology to a clinical tool. This review outlines key steps in the development of a clinical hemostasis and thrombosis genetics service leveraging a multigene panel. We discuss its value across inherited bleeding, platelet, and thrombotic disorders (BPTDs) in the context of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Blood Platelet Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Hemorrhage

Share to Hemostasis

Share to High-Throughput Nucleotide Sequencing

Share to Predictive Value of Tests

Share to Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 40345666
DOI: 10.1016/j.jtha.2025.04.026
PMCID: PMC12212629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders.PMID 40345666Read ↗

Diagnostic high-throughput sequencing of 2,390 patients with bleeding, thrombotic and platelet disordersSemantic proximity Read ↗

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.Semantic proximity Read ↗

Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders.Semantic proximity Read ↗

Hemostatic phenotypes and genetic disordersSemantic proximity Read ↗

Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework.Semantic proximity Read ↗

High-throughput sequencing approaches for diagnosing hereditary bleeding and platelet disorders.Semantic proximity Read ↗

Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTHSemantic proximity Read ↗

High-throughput sequencing for diagnosing platelet disorders: lessons learned from exploring the causes of bleeding disorders.Semantic proximity Read ↗

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.Semantic proximity Read ↗

Molecular testing for disorders of hemostasis.Semantic proximity Read ↗

Molecular Diagnosis of Inherited Coagulation and Bleeding DisordersSemantic proximity Read ↗

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.